Detail akcie AngioDynamics online

Business Summary: AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Financial Summary: BRIEF: For the six months ended 30 November 2025, AngioDynamics, Inc. revenues increased 11% to $155.1M. Net loss decreased 27% to $17.3M. Revenues reflect Med Tech segment increase of 19% to $70.9M, Med Device segment increase of 4% to $84.2M, United States segment increase of 10% to $134.1M, International segment increase of 16% to $21.1M. Lower net loss reflects Plant closure decrease of 46% to $4.7M (expense).